BioCentury
ARTICLE | Clinical News

MIN-102: Phase I started

August 15, 2016 7:00 AM UTC

Minoryx began a double-blind, placebo-controlled, Dutch Phase I trial to evaluate single and multiple ascending doses of MIN-102 in healthy volunteers. ...